Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleGemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
- Where
- Hangzhou
- Age
- 18 years to 90 years
- People
- 480
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT03498326